APT Pharma Limited has acquired Universal Pharmaceutical Labs
APT Pharma Limited, a subsidiary of Jacobson Pharma Group, has acquired the entire shareholding in Universal Pharmaceutical Laboratories Ltd, a subsidiary of Li & Fung Group, for US$10.8 million.
APT Pharma Limited is a leading pharmaceutical manufacturer in Hong Kong, with manufacturing plants in both Hong Kong and Zhongshan.
Universal Pharmaceutical Laboratories Ltd manufactures and distributes private labeled pharmaceuticals, imported pharmaceuticals, health food and nutritional supplements, and various health and beauty care products in Hong Kong.
Li & Fung Group operates three core businesses: it designs, develops and sources consumer products for retailers worldwide; the group operates extensive logistics and distribution networks serving major brands globally. Another core business is retailing, where the company offers convenience stores and bakeries through Convenience Retail Asia Limited, luxury menswear through Trinity Limited, and toys and children's products through Toys (Labuan) Holding Limited.
Oaklins' team in Hong Kong advised the shareholders of APT Pharma Limited in this transaction.
Talk to the deal team
Related deals
sigo green GmbH has acquired the assets of sigo GmbH in the context of the insolvency in self-administration
sigo GmbH has sold its assets as part of a transferring reorganization to sigo green GmbH.
Learn moreDelaware Valley Floral Group has been acquired by Staple Street Capital
The owners of Delaware Valley Floral Group, Inc. (DVFG) have sold the company to Staple Street Capital.
Learn moreOTS has received valuation services
OTS Open Travel Services AG, a subsidiary of MTS Globe Group, is a leading hotel trading provider based in Glattbrugg, Switzerland. OTS acts as a B2B hotel trading intermediary paring travel sellers, such as travel agencies and tour operators with accommodation providers.
Learn more